期刊文献+

瑞替加滨的合成 被引量:5

Synthesis of Retigabine
原文传递
导出
摘要 对硝基苯胺经酰化、硝基还原、氨基保护、硝化、氨基脱保护,与对氟苯甲醛缩合得到N-[2-硝基-4-(4-氟苯亚甲胺基)苯基]氨基甲酸乙酯,再用Pd/C催化氢化同时还原硝基和亚胺得到抗癫痫药瑞替加滨,总收率约44%。 Retigabine, an anti-epileptic agent, was synthesized from 4-nitroaniline by acylation, reduction of nitro group, protection of amino group, nitration, deprotection of amino group, and then condensation with 4-fluorobenzaldehyde to give ethyl N- E4- E (4-fluorobenzylidene) amino] -2-nitrophenyl] carbamate, followed by Pd/C- catalyzed reduction of both nitro group and Schiffs base simultaneously with an overall yield about 44 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2013年第3期223-225,共3页 Chinese Journal of Pharmaceuticals
基金 国家"973"计划(2007CB512102) 国家自然科学基金重点项目(30730031)
关键词 瑞替加滨 抗癫痫药 合成 retigabine anti-epileptic agent synthesis
  • 相关文献

参考文献11

  • 1Cooper EC, Jan LY. M-channels: neurological diseases, neuromodulation, and drug development[J].Arch Neurol, 2003, 60 (4) : 496-500.
  • 2Cooper EC, Aldape KD, Abosch A, et al. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy [J]. Proc Nati Acad Sci USA, 2000, 97(9) : 4914-4919.
  • 3US FDA. FDA approves Potiga to treat seizures in adults [EB/OL]. [2011-06-13]. http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm 258834.htm.
  • 4Lankau HJ, Unverferth K, Arnold T, et al. Process for the production of 1,2,4-triaminobenzene carbamic acid esters: US, 20030023111 [P]. 2003-01-30.
  • 5左莉(编译),胡春(审校).依佐加滨(ezogabine)[J].中国药物化学杂志,2011,21(6):505-506. 被引量:2
  • 6Dieter HR, Engel J, Kutscher B, et al. Pharmaceutically active 1,2,4-triamino-benzene derivatives, processes for their preparation and pharmaceutical compositions containing: US, 5384330 [P]. 1993-01-08.
  • 7Vasantha B, Hemantha HP, Sureshbabu VV. 1- Propanephosphonic acid cyclic anhydride (T3P) as an efficient promoter for the Lossen rearrangement: application to the synthesis of urea and carbamate derivatives [J]. Synthesis, 2010, 17: 2990-2996.
  • 8Mario R, Andreas R. 1,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system: US, 20060014822 [P]. 2006-01-19.
  • 9Antonio G, Laurence G, Amelie L, et al. Quinazoline-urea, new protein kinase Inhibitors in treatment of prostate cancer EJ]. JEnzyme lnhib Med Chem, 2010, 25 (2) : 158-171.
  • 10Sobanov AA, Zolotukhin AV, Galkina IV, et al. Kinetics and mechanism of the Pudovik reaction in the azomethine series: III. Acid-catalyzed hydrophosphorylation of imines [J]. Russ d Gen Chem, 2006, 76 (3) : 421-429.

二级参考文献9

  • 1US FDA. FDA approves Potiga to treat seizures in adults[ EB/ OL ]. [ 2011 - 06 - 13 ]. http ://www. fda. gov/NewsEvents/ Newsroom/PressAnnouncements/ucm258834. htm.
  • 2谌伦华,蔡祖安,张志强,等.一种瑞替加滨中间体的简单合成方法:中国,2010/10242510[P].2010-08-02.
  • 3DIETER H-R, ENGEL J, KUTSCHER B, et al. Pharmaceuti- cally active 1,2,4-triamino-benzene derivatives, processes for their preparation and pharmaceutical compositions containing: US ,5384330 [ P]. 1993 - 01 - 08.
  • 4TATULIAN L, DALMAS P, ABOGADIE F C, et al. Activa- tion of expressed KCNQ potassium currents and native neuro- nal M-type potassium currents by the anti-convulsant drug retigabine[ J ]. J Neurosci ,2001,21 ( 15 ) :5535 - 5545.
  • 5RUNDFELDT C,NETZER R. The novel anti-convulsant reli- gabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits[ J]. Neurosci Lett, 2000,282(1/2) :73 -76.
  • 6CZUCZWAR P, WOJTAK A, CIOCZEK-CZUCZWAR A, et al. Retigabine: the newer potential antiepileptic drug [ J ]. Phar- macol Rep ,2010,62 (2) :211 - 219.
  • 7DOST R, RUNDFELDT C. The anticonvulsam potently sup- presses epileptiform discharges in the low Ca^2+ model in the hippocampal slice preparation [ J ]. Epilepsy Res, 2000, 38 (1) :53 -66.
  • 8KHARKOVETS T, HARDELIN J P, SAFIEDDINE S, et al. KCNQ4 ,a K^+ channel mutatek in foum of dominant deaf- ness,is expressed in the central auditory pathway [ J ]. Proc Natl Acad Sci USA,2000,97(8) :4333 -4338.
  • 9US FDA. FDA approves Potiga for the treatment of patients with epilepsy [ EB/OL]. [2011 - 06 - 13 ] http://www. accessdata, fda. gov/drugsatfda _ docs/label/2011/ 022345s0001b1. pdf.

共引文献1

同被引文献8

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部